Figure S4 from Identification of an imidazopyridine-based compound as an oral selective estrogen receptor degrader for breast cancer therapy
Year: 2023
Type: other
Abstract: X15695 derivatives attenuate AR target gene expression.
Authors: Mengwu Pan, Valeria Solozobova, Nane C. Kuznik, Nicole Jung, Simone Graessle, Victor Gourain, Yvonne M. Heneka, Christina Alexandra Cramer von Clausbruch, Olaf Fuhr, Ravi S.N. Munuganti, Danilo Maddalo, Christine Blattner, Antje Neeb, Adam Sharp, Laura Cato, Carsten Weiss, Rinath M. Jeselsohn, Veronique Orian-Rousseau, Stefan Bräse, Andrew C.B. Cato
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4383556715